03.25.25 -- Generic Drug Approvals In Canada: Use Of A Foreign-Sourced Reference Product As A Canadian Reference Product

Picking and sticking are the most common tablet defects that can reduce your product quality and performance. This makes perfecting the right pre-picking strategy essential to improving your processes.

A phase-appropriate quality approach ensures quality activities align with the unique risks and challenges of each development phase. Watch how to apply such an approach to CMC planning.

By 2025 and beyond, AI, structured data, and real-world evidence will reshape the landscape, driving personalized medicine and more efficient processes. Here are eight key trends to be aware of.

Have you considered the safety of your work environment’s air? Across industries, employers are determining how to detect inhalation hazards and, if present, how to protect employees from them.

Gain insight into the Return on Invested Capital (ROIC) advantages of an automated manufacturing facility and its correlation to the digital maturity of your operation.

Learn why proper training is vital in cleanroom cleaning and disinfection and how to develop and maintain a successful training initiative.

Discover how outsourcing this key aspect of bringing products to market can benefit your organization and overall supply chain optimization.

Examine the development and manufacturing expertise required to seamlessly transition from research to commercial stages to ensure smooth operation from early to late stage development.

Explore important initial steps to consider and implement during the process design phase which is a pre-requisite to a successful PPQ campaign and readiness for commercial manufacturing.

As peptide therapeutics continue to establish themselves as a leading technology, drug sponsors must identify reliable peptide building block suppliers to secure high-quality starting materials.

Although well-established processes, spray drying and hot-melt extrusion can be outperformed in bioavailability, cost-savings, manufacturing speed, environmental impact, and more.

See how a Protein A capture technology boosts mAb purification productivity 10-fold, supports membrane-based platforms, and enables intensified processes with improved yields.

Uncover how the Project Ready program was leveraged to streamline validation processes for a CDMO, resulting in a 25% reduction in budget and faster project completion.